 Itamar Medical Ltd. ITMR ITMR, a company that develops, manufactures and markets non-invasive diagnostic prescription medical devices to aid in the diagnosis of respiratory sleep disorders with a focus on the Core Sleep, Cardiology and Digital Health markets, today reported preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2019 and announced revenue guidance for the full year 2020. Total revenue for the fourth quarter of 2019 is expected to be 9.6 to 9.8 million, an increase of 46 to 49 compared to 6.6 million in the same quarter in 2018. 